Elective Discontinuation of Checkpoint Inhibitor Therapy in Patients with advanced Melanoma

被引：0
|
作者：
Persa, O. D. [1 ]
Schatton, K. [1 ]
Ruebben, A. [2 ]
Berking, C. [3 ]
Erdmann, M. [3 ]
Schlaak, M. [4 ]
Mauch, C. [5 ]
Steeb, T. [3 ]
机构：
[1] Uniklin Dusseldorf, Dusseldorf, Germany
[2] Uniklin Aachen, Aachen, Germany
[3] Uniklin Erlangen, Erlangen, Germany
[4] Charite Univ Med Berlin, Berlin, Germany
[5] Uniklin Koln, Cologne, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2021年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
eP 018
引用
收藏
页码：40 / 40
页数：1
相关论文
共 50 条
  • [1] Immune Checkpoint Inhibitor Therapy: A Boon to Elderly Patients with Advanced Melanoma?
    Muta, Tsuyoshi
    INTERNAL MEDICINE, 2018, 57 (16) : 2287 - 2288
  • [2] Impact of Immune Checkpoint Inhibitor Therapy on Quality of Life in Patients With Advanced Melanoma
    Jackson-Carroll, Natalie
    Whisenant, Meagan
    Crane, Stacey
    Johnson, Constance
    CANCER NURSING, 2023,
  • [3] Retreatment of Patients With Metastatic Cutaneous Melanoma Who Relapse After Elective Checkpoint Inhibitor Discontinuation After a Complete Remission
    Sadrolashrafi, Kaviyon
    Samlowski, Wolfram
    ONCOLOGIST, 2023, 28 (05): : E270 - E275
  • [4] The Symptom Experience of Patients with Advanced Melanoma Undergoing Immune Checkpoint Inhibitor (ICI) Therapy
    Jackson-Carroll, Natalie
    Johnson, Constance
    Tawbi, Hussein
    Wang, Xin Shelley
    Whisenant, Meagan
    SEMINARS IN ONCOLOGY NURSING, 2024, 40 (01)
  • [5] Feasibility of supervised telehealth exercise for patients with advanced melanoma receiving checkpoint inhibitor therapy
    Crosby, Brendan J.
    Newton, Robert U.
    Galvao, Daniel A.
    Taaffe, Dennis R.
    Lopez, Pedro
    Meniawy, Tarek M.
    Khattak, Muhammad A.
    Lam, Wei-Sen
    Gray, Elin S.
    Singh, Favil
    CANCER MEDICINE, 2023, 12 (13): : 14694 - 14706
  • [6] Outcome of Elective Checkpoint Inhibitor Discontinuation in Patients with Metastatic Melanoma Who Achieved a Complete Remission: Real-World Data
    Perez, Leanne
    Samlowski, Wolfram
    Lopez-Flores, Ruby
    BIOMEDICINES, 2022, 10 (05)
  • [7] Single or dual immune checkpoint inhibitor as adjuvant therapy in advanced melanoma
    Fukumoto, Takeshi
    Horita, Nobuyuki
    EUROPEAN JOURNAL OF CANCER, 2021, 147 : 140 - 141
  • [8] THE RISK OF DIARRHEA AND COLITIS IN PATIENTS WITH ADVANCED MELANOMA UNDERGOING IMMUNE-CHECKPOINT INHIBITOR THERAPY
    Tandon, Parul
    Bourassa-Blanchette, Samuel
    Bishay, Kirles
    Parlow, Simon
    Laurie, Scott A.
    McCurdy, Jeffrey D.
    GASTROENTEROLOGY, 2018, 154 (01) : S60 - S60
  • [9] THE RISK OF DIARRHEA AND COLITIS IN PATIENTS WITH ADVANCED MELANOMA UNDERGOING IMMUNE-CHECKPOINT INHIBITOR THERAPY
    Tandon, Parul
    Bourassa-Blanchette, Samuel
    Bishay, Kirles
    Parlow, Simon
    Laurie, Scott A.
    McCurdy, Jeffrey D.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S42 - S42
  • [10] Right ventricular and atrial strain in patients with advanced melanoma undergoing immune checkpoint inhibitor therapy
    Pohl, Julia
    Totzeck, Matthias
    Mincu, Raluca-, I
    Margraf, Simone M.
    Scheipers, Lena
    Michel, Lars
    Mahabadi, Amir A.
    Zimmer, Lisa
    Rassaf, Tienush
    Hendgen-Cotta, Ulrike B.
    ESC HEART FAILURE, 2022, 9 (05): : 3533 - 3542
12345